XML 21 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2017
Financial Instruments [Abstract]  
FINANCIAL INSTRUMENTS
FINANCIAL INSTRUMENTS 
 
In the normal course of its business, the Company purchases and sells various financial instruments, which include listed and unlisted equities, corporate and sovereign debt, commodities, futures, put and call options, currency forwards, other derivatives and similar instruments sold, not yet purchased.

   Fair Value Hierarchy

The Company’s financial instruments are carried at fair value, and the net unrealized gains or losses are included in net investment income (loss) in the condensed consolidated statements of income.
 
The following table presents the Company’s investments, categorized by the level of the fair value hierarchy as of September 30, 2017:
 
 
Fair value measurements as of September 30, 2017
 
 
Description
 
Quoted prices in
active markets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
 
 
($ in thousands)
Assets: 
 
 
 
 
 
 
 
 
Debt instruments
 
$

 
$
903

 
$
834

 
$
1,737

Listed equity securities
 
1,178,079

 
17,785

 

 
1,195,864

Commodities
 
119,349

 

 

 
119,349

Private and unlisted equity securities
 

 

 
6,127

 
6,127

 
 
$
1,297,428

 
$
18,688

 
$
6,961

 
$
1,323,077

Private equity funds measured at net asset value (1)
 
 
 
 
 
 
 
13,689

Total investments
 
 
 
 
 
 
 
$
1,336,766

Financial contracts receivable
 
$
16

 
$
20,628

 
$

 
$
20,644

Liabilities:
 
 
 
 
 
 
 
 
Listed equity securities, sold not yet purchased
 
$
(792,632
)
 
$

 
$

 
$
(792,632
)
Debt instruments, sold not yet purchased
 

 
(97,369
)
 

 
(97,369
)
Total securities sold, not yet purchased
 
$
(792,632
)
 
$
(97,369
)
 
$

 
$
(890,001
)
Financial contracts payable
 
$
(34
)
 
$
(10,375
)
 
$

 
$
(10,409
)

(1) Investments measured at fair value using the net asset value practical expedient have not been classified in the fair value hierarchy. The fair value amounts are presented in the above table to facilitate reconciliation to the condensed consolidated balance sheets.

The following table presents the Company’s investments, categorized by the level of the fair value hierarchy as of December 31, 2016:
 
 
Fair value measurements as of December 31, 2016
 
 
Description
 
Quoted prices in
active markets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
 
 
($ in thousands)
Assets: 
 
 
 
 
 
 
 
 
Debt instruments
 
$

 
$
21,819

 
$
654

 
$
22,473

Listed equity securities
 
823,421

 
20,580

 

 
844,001

Commodities
 
137,296

 

 

 
137,296

Private and unlisted equity securities
 

 

 
6,109

 
6,109

 
 
$
960,717

 
$
42,399

 
$
6,763

 
$
1,009,879

Private equity funds measured at net asset value (1)
 
 
 
 
 
 
 
12,658

Total investments
 
 
 
 
 
 
 
$
1,022,537

Financial contracts receivable
 
$
20

 
$
76,361

 
$

 
$
76,381

Liabilities:
 
 
 
 
 
 
 
 
Listed equity securities, sold not yet purchased
 
$
(770,267
)
 
$

 
$

 
$
(770,267
)
Debt instruments, sold not yet purchased
 

 
(89,635
)
 

 
(89,635
)
Total securities sold, not yet purchased
 
$
(770,267
)
 
$
(89,635
)
 
$

 
$
(859,902
)
Financial contracts payable
 
$

 
$
(2,237
)
 
$

 
$
(2,237
)

(1) Investments measured at fair value using the net asset value practical expedient have not been classified in the fair value hierarchy. The fair value amounts are presented in the above table to facilitate reconciliation to the condensed consolidated balance sheets.

 The following table presents the reconciliation of the balances for all investments measured at fair value using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2017

 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Three months ended September 30, 2017
 
 
Debt instruments
 
 Private and unlisted equity securities
 
 Total
 
 
 ($ in thousands)
Beginning balance
 
$
776

 
$
6,085

 
$
6,861

Total realized and unrealized gains (losses) and amortization included in earnings, net
 
58

 
42

 
100

Ending balance
 
$
834

 
$
6,127

 
$
6,961



 
 
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Nine months ended September 30, 2017
 
 
Debt instruments
 
 Private and unlisted equity securities
 
 Total
 
 
 ($ in thousands)
Beginning balance
 
$
654

 
$
6,109

 
$
6,763

Purchases
 

 
1,750

 
1,750

Total realized and unrealized gains (losses) and amortization included in earnings, net
 
180

 
36

 
216

Transfers out of Level 3
 

 
(1,768
)
 
(1,768
)
Ending balance
 
$
834

 
$
6,127

 
$
6,961



During the nine months ended September 30, 2017, $1.8 million of the private equity securities were transferred from Level 3 as these securities commenced trading on a listed exchange. However, due to lock-up period restrictions on those securities, they were classified as Level 2. During the three months ended September 30, 2017, the lock-up period expired and these securities were transfered from Level 2 to Level 1 with the fair value based on the last traded price on an active market.
 
There were no other transfers between Level 1, Level 2 or Level 3 during the three and nine months ended September 30, 2017.

The following table presents the reconciliation of the balances for all investments measured at fair value using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2016:

 
 
  Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Three months ended September 30, 2016
 
 
Debt instruments
 
 Private and unlisted equity securities
 
 Total
 
 
 ($ in thousands)
Beginning balance
 
$
586

 
$
5,987

 
$
6,573

Total realized and unrealized gains (losses) and amortization included in earnings, net
 
56

 
124

 
180

Ending balance
 
$
642

 
$
6,111

 
$
6,753



 
 
  Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
 
 
Nine months ended September 30, 2016
 
 
Debt instruments
 
 Private and unlisted equity securities
 
Total
 
 
 ($ in thousands)
Beginning balance
 
$
505

 
$
8,452

 
$
8,957

Sales
 

 
(2,539
)
 
(2,539
)
Total realized and unrealized gains (losses) and amortization included in earnings, net
 
137

 
198

 
335

Ending balance
 
$
642

 
$
6,111

 
$
6,753



There were no transfers between Level 1, Level 2 or Level 3 during the three and nine months ended September 30, 2016.

As of September 30, 2017, the Company held investments in private equity funds of $13.7 million (December 31, 2016: $12.7 million) with fair values measured using the unadjusted net asset values as reported by the managers of these funds as a practical expedient. Some of these net asset values were reported from periods prior to September 30, 2017. The private equity funds have varying lock-up periods and, as of September 30, 2017, all of the funds had redemption restrictions. The redemption restrictions have been in place since inception of the investments and are not expected to lapse in the near future. As of September 30, 2017, the Company had $7.2 million (December 31, 2016: $9.2 million) of unfunded commitments relating to private equity funds whose fair values are determined based on unadjusted net asset values reported by the managers of these funds. These commitments are included in the amounts presented in the schedule of commitments and contingencies in Note 9 of these condensed consolidated financial statements.  

For the three and nine months ended September 30, 2017, included in net investment income in the condensed consolidated statements of income were no net realized losses relating to Level 3 securities (2016: nil and $1.4 million, respectively).

For Level 3 securities still held as of the reporting date, the change in net unrealized gain for the three and nine months ended September 30, 2017 of $0.1 million and $0.2 million, respectively (three and nine months ended September 30, 2016: net unrealized losses of $0.2 million and $1.7 million), were included in net investment income (loss) in the condensed consolidated statements of income.
  
Investments
 
Debt instruments, trading
 
At September 30, 2017, the following investments were included in debt instruments:
 
 
Cost/amortized cost
 
Unrealized gains
 
Unrealized losses
 
Fair
 value
 
 
($ in thousands)
Corporate debt – U.S.
 
$
8,508

 
$

 
$
(6,874
)
 
$
1,634

Corporate debt – Non U.S.
 
2,109

 

 
(2,006
)
 
103

Total debt instruments
 
$
10,617

 
$

 
$
(8,880
)
 
$
1,737


 
At December 31, 2016, the following investments were included in debt instruments:
 
 
Cost/amortized cost
 
Unrealized gains
 
Unrealized losses
 
Fair
 value
 
 
($ in thousands)
Corporate debt – U.S.
 
$
21,294

 
$
6,509

 
$
(5,331
)
 
$
22,472

Corporate debt – Non U.S.
 
2,109

 

 
(2,108
)
 
1

Total debt instruments
 
$
23,403

 
$
6,509

 
$
(7,439
)
 
$
22,473



The maturity distribution for debt instruments held at September 30, 2017 and December 31, 2016 was as follows:
 
 
September 30, 2017
 
December 31, 2016
 
 
Cost/
 amortized
 cost
 
Fair
 value
 
Cost/
 amortized
 cost
 
Fair
 value
 
 
($ in thousands)
Within one year
 
$
6,106

 
$
741

 
$

 
$

From one to five years
 
1,451

 
59

 
17,803

 
19,492

From five to ten years
 
2,109

 
103

 
4,649

 
2,327

More than ten years
 
951

 
834

 
951

 
654

 
 
$
10,617

 
$
1,737

 
$
23,403

 
$
22,473


 
Equity securities, trading

At September 30, 2017, the following long positions were included in equity securities, trading: 
 
 
Cost
 
Unrealized
gains
 
Unrealized
losses
 
Fair
value
 
 
($ in thousands)
Equities – listed
 
$
1,013,956

 
$
214,617

 
$
(49,737
)
 
$
1,178,836

Exchange traded funds
 
15,056

 
1,972

 

 
17,028

Total equity securities
 
$
1,029,012

 
$
216,589

 
$
(49,737
)
 
$
1,195,864



At December 31, 2016, the following long positions were included in equity securities, trading:
 
 
Cost
 
Unrealized
gains
 
Unrealized
losses
 
Fair
value
 
 
($ in thousands)
Equities – listed
 
$
753,813

 
$
115,379

 
$
(40,706
)
 
$
828,486

Exchange traded funds
 
15,056

 
459

 

 
15,515

Total equity securities
 
$
768,869

 
$
115,838

 
$
(40,706
)
 
$
844,001



Other Investments
 
“Other investments” include commodities and private and unlisted equity securities. As of September 30, 2017 and December 31, 2016, all commodities were comprised of gold bullion. 

At September 30, 2017, the following securities were included in other investments:
 
 
Cost
 
Unrealized
gains
 
Unrealized
losses
 
Fair
value
 
 
($ in thousands)
Commodities
 
$
101,184

 
$
18,165

 
$

 
$
119,349

Private and unlisted equity securities
 
14,801

 
5,015

 

 
19,816

 
 
$
115,985

 
$
23,180

 
$

 
$
139,165



At December 31, 2016, the following securities were included in other investments: 
 
 
Cost
 
Unrealized
gains
 
Unrealized
losses
 
Fair
value
 
 
($ in thousands)
Commodities
 
$
130,671

 
$
6,625

 
$

 
$
137,296

Private and unlisted equity securities
 
14,418

 
4,375

 
(26
)
 
18,767

 
 
$
145,089

 
$
11,000

 
$
(26
)
 
$
156,063



Investments in Securities Sold, Not Yet Purchased 

Securities sold, not yet purchased, are securities that the Company has sold, but does not own, in anticipation of a decline in the market value of the security. The Company’s risk is that the value of the security will increase rather than decline. Consequently, the settlement amount of the liability for securities sold, not yet purchased, may exceed the amount recorded in the condensed consolidated balance sheet as the Company is obligated to purchase the securities sold, not yet purchased, in the market at prevailing prices to settle its obligations. To establish a position in a security sold, not yet purchased, the Company needs to borrow the security for delivery to the buyer. On each day the transaction is open, the liability for the obligation to replace the borrowed security is marked-to-market and an unrealized gain or loss is recorded. At the time the transaction is closed, the Company realizes a gain or loss equal to the difference between the price at which the security was sold and the cost of replacing the borrowed security. While the transaction is open, the Company will also incur an expense for any dividends or interest which will be paid to the lender of the securities.

At September 30, 2017, the following securities were included in investments in securities sold, not yet purchased:
 
 
Proceeds
 
Unrealized gains
 
Unrealized losses
 
 Fair value
 
 
($ in thousands)
Equities – listed
 
$
(646,419
)
 
$
27,120

 
$
(173,333
)
 
$
(792,632
)
Sovereign debt – Non U.S.
 
(96,230
)
 

 
(1,139
)
 
(97,369
)
 
 
$
(742,649
)
 
$
27,120

 
$
(174,472
)
 
$
(890,001
)


At December 31, 2016, the following securities were included in investments in securities sold, not yet purchased: 
 
 
Proceeds
 
Unrealized gains
 
Unrealized losses
 
 Fair value
 
 
($ in thousands)
Equities – listed
 
$
(690,270
)
 
$
30,768

 
$
(110,765
)
 
$
(770,267
)
Sovereign debt – Non U.S.
 
(96,230
)
 
6,595

 

 
(89,635
)
 
 
$
(786,500
)
 
$
37,363

 
$
(110,765
)
 
$
(859,902
)

 
Financial Contracts
 
As of September 30, 2017 and December 31, 2016, the Company had entered into total return equity swaps, interest rate swaps, commodity swaps, options, warrants, rights, futures and forward contracts with various financial institutions to meet certain investment objectives. Under the terms of each of these financial contracts, the Company is either entitled to receive or is obligated to make payments, which are based on the product of a formula contained within each contract that includes the change in the fair value of the underlying or reference security.

At September 30, 2017, the fair values of financial contracts outstanding were as follows: 
Financial Contracts
 
Listing
currency
 (1)
 
Notional amount of
underlying instruments
 
Fair value of net assets
(obligations)
on financial
contracts
 
 
 
 
($ in thousands)
Financial contracts receivable
 
 
 
 
 
 
Call options
 
USD
 
14,008

 
$
887

Commodity Swaps
 
USD
 
34,190

 
2,392

Interest rate swaps
 
JPY
 
21,286

 
302

Put options (2)
 
USD
 
1,363

 
8

Total return swaps – equities
 
EUR/RON/USD
 
46,686

 
17,037

Warrants and rights on listed equities
 
EUR/USD
 
52

 
18

Total financial contracts receivable, at fair value
 
 
 
 
 
$
20,644

Financial contracts payable
 
 
 
 
 
 
Commodity Swaps
 
USD
 
17,833

 
$
(104
)
Forwards
 
KRW
 
12,611

 
(124
)
Futures
 
USD
 
5,773

 
(34
)
Put options
 
USD
 
253

 
(42
)
Total return swaps – equities
 
BRL/EUR/GBP/KRW/USD
 
57,616

 
(10,105
)
Total financial contracts payable, at fair value
 
 
 
 
 
$
(10,409
)
(1) USD = US Dollar; BRL = Brazilian Real; EUR = Euro; GBP = British Pound; JPY = Japanese Yen; KRW = Korean Won; RON = Romanian New Leu.
(2) Includes options on the Chinese Yuan, denominated in U.S. dollars.

At December 31, 2016, the fair values of financial contracts outstanding were as follows: 
Financial Contracts
 
Listing currency (1)
 
Notional amount of
underlying instruments
 
Fair value of net assets
(obligations)
on financial
contracts
 
 
 
 
($ in thousands)
Financial contracts receivable
 
 
 
 
 
 
Call options
 
USD
 
134,495

 
$
26,508

Commodity Swaps
 
USD
 
82,009

 
13,506

Interest rate swaps
 
JPY
 
20,490

 
218

Put options (2)
 
USD
 
115,481

 
6,703

Total return swaps – equities
 
EUR/GBP/USD
 
100,199

 
29,413

Warrants and rights on listed equities
 
EUR/USD
 
67

 
33

Total financial contracts receivable, at fair value
 
 
 
 
 
$
76,381

Financial contracts payable
 
 
 
 
 
 
Forwards
 
KRW
 
6,880

 
$
(118
)
Put options
 
USD
 
815

 
(172
)
Total return swaps – equities
 
EUR/GBP/KRW/RON/USD
 
31,257

 
(1,947
)
Total financial contracts payable, at fair value
 
 
 
 
 
$
(2,237
)

(1) USD = US Dollar; EUR = Euro; GBP = British Pound; JPY = Japanese Yen; KRW = Korean Won; RON = Romanian New Leu.
(2) Includes options on the Japanese Yen and the Chinese Yuan, denominated in U.S. dollars.
Options are derivative financial instruments that give the buyer, in exchange for a premium payment, the right, but not the obligation, to either purchase from (call option) or sell to (put option) the writer, a specified underlying security at a specified price on or before a specified date. The Company enters into option contracts to meet certain investment objectives. For exchange traded option contracts, the exchange acts as the counterparty to specific transactions and therefore bears the risk of delivery to and from counterparties of specific positions.

As of September 30, 2017, the Company held $0.0 million OTC put options (long) (December 31, 2016: $6.7 million), $0.3 million OTC call options (long) (December 31, 2016: $22.4 million), and $0.0 million OTC put options (short) (December 31, 2016: $0.2 million).

During the three and nine months ended September 30, 2017 and 2016, the Company reported gains and losses on derivatives as follows:
Derivatives not designated as hedging instruments
 
Location of gains and losses on derivatives recognized in income
 
Gain (loss) on derivatives recognized in income
 
 
 
 
Three months ended September 30
 
Nine months ended September 30
 
 
 
 
2017
 
2016
 
2017
 
2016
 
 
 
 
($ in thousands)
Forwards
 
Net investment income (loss)
 
$
(28
)
 
$
(116
)
 
$
306

 
$
(184
)
Futures
 
Net investment income (loss)
 
(77
)
 
793

 
(480
)
 
2,086

Interest rate swaps
 
Net investment income (loss)
 
113

 

 
20

 

Options, warrants, and rights
 
Net investment income (loss)
 
(6,467
)
 
(2,834
)
 
(18,579
)
 
(5,082
)
Commodity swaps
 
Net investment income (loss)
 
1,794

 
(1,476
)
 
(8,911
)
 
(1,195
)
Total return swaps – equities
 
Net investment income (loss)
 
12,635

 
7,769

 
12,353

 
21,573

Total
 
 
 
$
7,970

 
$
4,136

 
$
(15,291
)
 
$
17,198



The Company generally does not enter into derivatives for risk management or hedging purposes. The volume of derivative activities varies from period to period depending on potential investment opportunities.

For the three and nine months ended September 30, 2017, the Company’s volume of derivative activities (based on notional amounts) was as follows:
2017
 
Three months ended September 30
 
Nine months ended September 30
Derivatives not designated as hedging instruments (notional amounts)
 
  Entered
 
Exited
 
  Entered
 
Exited
 
 
($ in thousands)
Forwards
 
$
1,781

 
$

 
$
5,421

 
$

Futures
 
5,807

 
2,650

 
38,207

 
32,537

Options, warrants and rights (1)
 
372,894

 
15,840

 
950,811

 
125,942

Commodity swaps
 

 
17,729

 
2,025

 
34,317

Total return swaps
 

 
20,147

 
243,495

 
316,560

Total
 
$
380,482

 
$
56,366

 
$
1,239,959

 
$
509,356


(1) Exited amount excludes derivatives that expired or were exercised during the period.

For the three and nine months ended September 30, 2016, the Company’s volume of derivative activities (based on notional amounts) was as follows:
2016
 
Three months ended September 30
 
Nine months ended September 30
Derivatives not designated as hedging instruments (notional amounts)
 
  Entered
 
Exited
 
  Entered
 
Exited
 
 
($ in thousands)
Forwards
 
$

 
$
2,950

 
$

 
$
3,128

Futures
 
1,603,250

 
1,578,692

 
1,777,971

 
1,773,858

Options, warrants and rights (1)
 
215,008

 
65,625

 
368,547

 
324,327

Commodity swaps
 

 
6,257

 
75,566

 
70,282

Total return swaps
 
33,479

 
10,501

 
35,529

 
59,766

Total
 
$
1,851,737

 
$
1,664,025

 
$
2,257,613

 
$
2,231,361


(1) Exited amount excludes derivatives that expired or were exercised during the period.

The Company does not offset its derivative instruments and presents all amounts in the condensed consolidated balance sheets on a gross basis. The Company has pledged cash collateral to derivative counterparties to support the current value of amounts due to the counterparties on its derivative instruments.

As of September 30, 2017, the gross and net amounts of derivative instruments and the cash collateral applicable to derivative instruments were as follows:
September 30, 2017
 
(i)
 
(ii)
 
(iii) = (i) - (ii)
 
(iv) Gross amounts not offset in the balance sheet
 
(v) = (iii) + (iv)
Description
 
Gross amounts of recognized assets (liabilities)
 
Gross amounts offset in the balance sheet
 
Net amounts of assets (liabilities) presented in the balance sheet
 
Financial instruments available for offset
 
Cash collateral (received) pledged
 
Net amount of asset (liability)
 
 
($ in thousands)
Financial contracts receivable
 
$
20,644

 
$

 
$
20,644

 
$
(5,509
)
 
$
(10,695
)
 
$
4,440

Financial contracts payable
 
(10,409
)
 

 
(10,409
)
 
5,509

 
4,900

 



As of December 31, 2016, the gross and net amounts of derivative instruments and the cash collateral applicable to derivative instruments were as follows:
December 31, 2016
 
(i)
 
(ii)
 
(iii) = (i) - (ii)
 
(iv) Gross amounts not offset in the balance sheet
 
(v) = (iii) + (iv)
Description
 
Gross amounts of recognized assets (liabilities)
 
Gross amounts offset in the balance sheet
 
Net amounts of assets (liabilities) presented in the balance sheet
 
Financial instruments available for offset
 
Cash collateral (received) pledged
 
Net amount of asset (liability)
 
 
($ in thousands)
Financial contracts receivable
 
$
76,381

 
$

 
$
76,381

 
$
(938
)
 
$
(44,572
)
 
$
30,871

Financial contracts payable
 
(2,237
)
 

 
(2,237
)
 
938

 
1,299